2016
Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort
Callegari LS, Gray KE, Zephyrin LC, Harrington LB, Gerber MR, Cochrane BB, Weitlauf JC, Bean-Mayberry B, Bastian LA, Mattocks KM, Haskell SG, Katon JG. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort. The Gerontologist 2016, 56: s67-s77. PMID: 26768393, PMCID: PMC5881615, DOI: 10.1093/geront/gnv666.Peer-Reviewed Original ResearchConceptsPrevalence of hysterectomyEarly hysterectomyWomen veteransBirth cohortUnadjusted prevalenceWomen's Health Initiative clinical trialsBilateral salpingo-oophorectomyLogistic regression modelsPostmenopausal veteransSalpingo-oophorectomyMultinomial logistic regression modelsClinical trialsHigh prevalenceObservational studyHysterectomyHigher oddsElevated riskClinical practiceHealth needsCohortPrevalenceBaseline dataVeteransHealth risksRisk
2001
Racial Differences in Physician Recommendation of Hormone Replacement Therapy
Weng H, McBride C, Bosworth H, Grambow S, Siegler I, Bastian L. Racial Differences in Physician Recommendation of Hormone Replacement Therapy. Preventive Medicine 2001, 33: 668-673. PMID: 11716665, DOI: 10.1006/pmed.2001.0943.Peer-Reviewed Original ResearchConceptsHormone replacement therapyPhysician recommendationWhite womenReplacement therapyBenefits of HRTBlack womenPatient-provider communicationAssociation of raceWomen age 45Racial differencesLogistic regression analysisHealth care providersAge 45Care providersBaseline assessmentOlder ageWomenRegression analysisTherapyWomen's decisionsHysterectomyAdditional factorsPrevious studiesRecommendationsFactors
1995
Cytologic screening after hysterectomy for benign disease
Piscitelli J, Bastian L, Wilkes A, Simel D. Cytologic screening after hysterectomy for benign disease. American Journal Of Obstetrics And Gynecology 1995, 173: 424-432. PMID: 7645617, DOI: 10.1016/0002-9378(95)90262-7.Peer-Reviewed Original ResearchConceptsBenign diseaseCytologic abnormalitiesVaginal dysplasiaInvasive gynecologic malignancyLow-risk patientsAbnormal cytology resultsCervical cytologic abnormalitiesProportional hazards regressionKaplan-Meier estimatesLittle clinical significanceMain outcome variablesTrue positive casesGynecologic malignanciesRetrospective cohortHazards regressionCytology resultsCytology testDysplasia casesClinical significanceLower incidencePositive casesPatientsScreening testHysterectomyOutcome variables